<DOC>
	<DOCNO>NCT00778466</DOCNO>
	<brief_summary>The objective study evaluate relative bioavailability test formulation metformin hydrochloride 1000 mg tablet already market reference formulation GLUCOPHAGE® ( metformin hydrochloride ) 1000 mg tablet ( Bristol-Myers Squibb Company ) feed condition healthy , male female adult subject .</brief_summary>
	<brief_title>Bioequivalence Study Metformin Hydrochloride 1000mg Tablets Under Fed Conditions</brief_title>
	<detailed_description>This randomize , single-dose , two-way , crossover study conduct compare relative bioavailability two formulation 1000 mg metformin hydrochloride tablet feed condition . The study conduct 32 ( 30 complete ) healthy adult accordance Protocol No . 10640303 ( Revision 0 ) . In study period , single dose ( 1 x 1000 mg tablet ) administer subject follow standardized high fat breakfast precede overnight fast least 10 hour . The test formulation Ohm Laboratories , Inc 's ( A Group Ranbaxy Pharmaceuticals Inc. ) Metformin Hydrochloride 1000 mg Tablets reference formulation GLUCOPHAGE® ( metformin hydrochloride ) 1000 mg Tablets ( Bristol-Myers Squibb Company ) . The subject receive test product one study period reference product period ; order administration accord dose randomization schedule . There 7-day interval treatment . Blood sample collect pre-dose interval 24 hour dose . The plasma sample subject complete period study send Helen Fassoulas , Director Operations , Warnex Bioanalytical Services Inc. , 3885 boul Industriel , Laval , Quebec , H7L4S3 Canada , Telephone : 450-663-6724 , Fax : 450-975-8111 determination metformin concentration . Statistical analysis perform Braulio Suarez , M.D. , Novum Pharmaceutical Research Services , Wilcrest Green Office Park , 3320 Walnut Bend Lane , Houston , Texas 77042-4712 , USA , Telephone : 832-251-8100 , Fax : 832-251-7133 . A total 32 healthy adult subject ( 30 complete ) .</detailed_description>
	<mesh_term>Metformin</mesh_term>
	<criteria>1 . Males female , 18 60 year age ( inclusive ) . 2 . A body mass index ( BMI ) 1830 kg/m2 inclusive calculate accord Novum Standard Operating Procedures . 3 . Good health determine lack clinically significant abnormality health assessment perform screen . 4 . Signed date informed consent form , meet criteria current FDA regulation . 5 . Female subject child bear potential must either abstain sexual intercourse use reliable method contraception ( e.g . condom spermicide , IUD , hormonal contraceptive ) least 30 day prior dose duration study . 1 . If female , pregnant , lactate likely become pregnant study . 2 . History allergy sensitivity metformin , hyperglycemic agent , history drug hypersensitivity intolerance , opinion Investigator , would compromise safety subject study . 3 . Significant history current evidence chronic infectious disease , system disorder organ dysfunction . 4 . Presence gastrointestinal disease history malabsorption within last year . 5 . History psychiatric disorder occur within last two year require hospitalization medication . 6 . Presence medical condition require regular treatment prescription drug . 7 . Use pharmacologic agent know significantly induce inhibit drugmetabolizing enzyme within 30 day prior dose . 8 . Receipt drug part research study within 30 day prior dose . 9 . Drug alcohol addiction require treatment past 12 month . 10 . Donation significant loss whole blood ( 480 ml ) within 30 day plasma within 14 day prior dose . 11 . Positive test result HIV , Hepatitis B surface antigen Hepatitis C antibody . 12 . Positive test result drug abuse screen . 13 . Positive serum pregnancy test .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>Bioequivalence metformin hydrochloride 1000 mg tablet feed condition</keyword>
</DOC>